BioSpace News Archive

Drug Development

CTI BioPharma Announces Outcome From End-of-Phase-2a Meeting With U.S. Food and Drug Administration (FDA) Regarding Pacritinib for Treatment of Myelofibrosis

Company Plans to Advance Pacritinib 200 mg Twice-Daily (BID) Dose to Phase 3 for Patients With Severe Thrombocytopenia

July 18, 2019
·
8 min read
Deals

Acorda Second Quarter 2019 Update: Webcast/Conference Call Scheduled for August 1, 2019

Acorda Therapeutics, Inc. will host a conference call and webcast to report its second quarter 2019 update and financial results on Thursday, August 1 at 4:30 p.m. ET.

July 18, 2019
·
3 min read
Drug Development

LifeMax Receives Rare Pediatric Disease Designation for LM-030 for the Treatment of Netherton Syndrome

LifeMax Laboratories, Inc. announced that the Food & Drug Administration granted rare pediatric disease designation to LM-030, an investigational therapy licensed from Novartis and ready to enter into pivotal clinical trials for the treatment of Netherton Syndrome.

July 18, 2019
·
2 min read
Business

Immunocore and Pulse Infoframe, Inc. Partner with Leading Academic Institutions to Launch First Global Patient Registry for Uveal Melanoma

Patient-reported data will help inform research in rare form of eye cancer

July 18, 2019
·
5 min read
Medicare Releases Final Local Coverage Determination Providing Coverage of Optune® for Newly Diagnosed Glioblastoma

Novocure announced the Medicare durable medical equipment Medicare Administrative Contractors have released a final local coverage determination providing coverage of Optune for Medicare beneficiaries with newly diagnosed glioblastoma effective September 1, 2019.

July 18, 2019
·
7 min read
BioMidwest

Walgreens Earns Best Place to Work in 2019 Disability Equality Index

National Recognition Spotlights Walgreens Training and Job Readiness Programs

July 18, 2019
·
4 min read
BioMidwest

Parents say kids’ oral health not making the grade observes Delta Dental survey

Parents’ perceptions of their children’s oral health decline as kids age

July 18, 2019
·
2 min read
Drug Development

Moleculin Announces Annamycin in Acute Myeloid Leukemia in Poland Advances to 3rd Cohort

Moleculin Biotech, Inc., announced additional positive interim safety and efficacy data from its ongoing open label, single arm Phase 1/2 study of Annamycin in Poland.

July 18, 2019
·
5 min read
Business

Neuralstem Appoints Mary Ann Gray, Ph.D., to Board of Directors

Neuralstem, Inc. announced that Mary Ann Gray, Ph.D. has been appointed to the Company’s Board of Directors.

July 18, 2019
·
4 min read
Business

Regeneron Announces the 2019 Winners of the Regeneron Prize for Creative Innovation

Regeneron Pharmaceuticals, Inc. announced the winners of the seventh annual Regeneron Prize for Creative Innovation.

July 18, 2019
·
6 min read